Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Desmopressin
Drug ID BADD_D00616
Description Desmopressin (dDAVP), a synthetic analogue of 8-arginine vasopressin (ADH), is an antidiuretic peptide drug modified by deamination of 1-cysteine and substitution of 8-L-arginine by 8-D-arginine. ADH is an endogenous pituitary hormone that has a crucial role in the control of the water content in the body. Upon release from the stimulation of increased plasma osmolarity or decreased circulating blood volume, ADH mainly acts on the cells of the distal part of the nephron and the collecting tubules in the kidney [T28]. The hormone interacts with V1, V2 or V3 receptors with differing signal cascade systems. Desmopressin displays enhanced antidiuretic potency, fewer pressor effects due to V2-selective actions, and a prolonged half-life and duration of action compared to endogenous ADH [A31661]. It has been employed clinically since 1972 and is available in various formulations including intranasal solution, intravenous solution, oral tablet and oral lyophilisate [A31662]. Desmopressin is indicated for the treatment of polyuric conditions including primary nocturnal enuresis, nocturia, and diabetes insipidus. It was also newly approved for the treatment of mild classical hemophilia and von Willebrand's disease for minor surgeries. The active ingredient in most formulations is desmopressin acetate. Nocdurna, or desmopressin acetate, was approved by the FDA on June 21st, 2018 for the treatment of nocturia due to nocturnal polyuria in adults. It is available as a sublingual tablet.
Indications and Usage - Indicated for patients with hemophilia A with factor VIII coagulant activity levels greater than 5% or mild to moderate classic von Willebrand's Disease (Type I) with factor VIII levels greater than 5% during surgical procedures and postoperatively to m
Marketing Status Prescription; Discontinued
ATC Code H01BA02
DrugBank ID DB00035
KEGG ID D00291
MeSH ID D003894
PubChem ID 5311065
TTD Drug ID D0U7SH
NDC Product Code 52416-115; 41701-007; 62938-0023; 52416-108; 60870-0440; 62938-0024
Synonyms Deamino Arginine Vasopressin | Arginine Vasopressin, Deamino | 1-Desamino-8-arginine Vasopressin | Vasopressin, 1-Desamino-8-arginine | Desmopressin | Vasopressin, Deamino Arginine | 1-Deamino-8-D-arginine Vasopressin | Vasopressin, 1-Deamino-8-D-arginine | Adiuretin SD | Apo-Desmopressin | DDAVP | Octostim | Desmotabs | Octim | Desmopressine Ferring | Ferring, Desmopressine | Desmospray | Nocutil | Desmopressin Acetate | Acetate, Desmopressin | Desmopressin Monoacetate, Trihydrate | Monoacetate, Trihydrate Desmopressin | Trihydrate Desmopressin Monoacetate | Desmopressin Monoacetate | Monoacetate, Desmopressin | Minirin | Minurin | Adiuretin | Desmogalen
Chemical Information
Molecular Formula C46H64N14O12S2
CAS Registry Number 16679-58-6
SMILES C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)C C3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
ThrombophlebitisProtein kinase C delta typeQ05655T448613840287; 2363094; 8800154; 2146406
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Dehydration14.05.05.0010.007841%
Depressed level of consciousness17.02.04.002--
Depressed mood19.15.02.001--Not Available
Depression19.15.01.001--
Dermatitis23.03.04.002--Not Available
Dermatitis atopic10.01.04.004; 23.03.04.016--Not Available
Diabetes insipidus14.05.07.003; 05.03.03.0040.003921%Not Available
Diarrhoea07.02.01.001--
Discomfort08.01.08.003--Not Available
Disorientation19.13.01.002; 17.02.05.0150.003921%Not Available
Disturbance in attention19.21.02.002; 17.03.03.001--
Dizziness24.06.02.007; 17.02.05.003; 02.01.02.0040.033325%
Drug interaction08.06.03.001--Not Available
Drug withdrawal syndrome19.07.02.011; 08.06.02.0040.003921%Not Available
Dyspepsia07.01.02.001--
Dyspnoea22.02.01.004; 02.01.03.002--
Ear disorder04.03.01.001--Not Available
Emotional disorder19.04.02.005--Not Available
Enuresis20.02.02.003; 19.07.04.001--Not Available
Epistaxis24.07.01.005; 22.04.03.0010.074490%
Erythema23.03.06.0010.017642%Not Available
Eye disorder06.08.03.001--Not Available
Fatigue08.01.01.002--
Feeling abnormal08.01.09.0140.007841%Not Available
Feeling hot08.01.09.0090.007841%Not Available
Feeling jittery08.01.09.0160.003921%Not Available
Flatulence07.01.04.002--
Fluid retention14.05.06.002; 20.01.02.0030.007841%Not Available
Flushing08.01.03.025; 24.03.01.002; 23.06.05.0030.064689%
Gastroenteritis11.01.07.004; 07.19.03.001--Not Available
The 2th Page    First    Pre   2 3 4 5 6    Next   Last    Total 7 Pages